logo_web_wht
FREE CONSULTATION
(888) 637-5510

Tag: Relmada Therapeutics investor relations

Camp Nine

Blog, Current Investigations

May 7, 2018

Relmada Therapeutics (fka Camp Nine, Inc.) – Securities Investigation

Relmada Therapeutics (Camp Nine) – Investigating Potential Claims Are you concerned about your investment in Relmada Therapeutics? If...

Read More →
Relmada Therapeutics

Current Investigations

January 2, 2018

Relmada Therapeutics – Private Placement – Securities Investigation

Investigating potential claims involving Relmada Therapeutics Relmada Therapeutics is a clinical-stage, publicly traded biotechnology...

Read More →
Investment Losses?
Contact our National Securities Fraud Attorneys
GET A FREE CONSULTATION

Why Hire The White Law Group?

$50 M
Recovered for Investors
30 Years
of Securities Law Experience
700+
FINRA Arbitration Cases
50 States
Representing Investors
5-Star
AVVO Attorney Rating
Contingency Based Fees
logo_web_wht2
(312) 238-9650 | Fax: (312) 238-8950 | (888) 637-5510 | 125 S. Wacker Drive, Suite 300, Chicago, Illinois 60606 The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation. You may reproduce materials available at this site for your own personal use and for non-commercial distribution. All copies must include this copyright statement. © 2023 by The White Law Group, LLC All rights reserved.
PRIVACY POLICY

SITE MAP